aTyr Pharma (ATYR)
(Delayed Data from NSDQ)
$1.89 USD
+0.02 (1.07%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $1.88 -0.01 (-0.53%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.23 |
EPS Last Quarter | -0.23 |
Last EPS Surprise | -4.55% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.94 |
Next Year | -0.95 |
EPS (TTM) | -0.91 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.13M | 0.14M | 0.37M | 12.60M |
# of Estimates | 1 | 1 | 2 | 1 |
High Estimate | 0.13M | 0.14M | 0.50M | 12.60M |
Low Estimate | 0.13M | 0.14M | 0.24M | 12.60M |
Year ago Sales | 0.35M | 0.00M | 0.35M | 0.37M |
Year over Year Growth Est. | -62.86% | NA | 4.82% | 3,305.41% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.23 | -0.25 | -0.94 | -0.95 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.22 | -0.24 | -0.92 | -0.92 |
High Estimate | -0.22 | -0.24 | -0.92 | -0.92 |
Low Estimate | -0.24 | -0.25 | -0.96 | -0.97 |
Year ago EPS | -0.20 | -0.25 | -0.94 | -0.94 |
Year over Year Growth Est. | -15.00% | 0.00% | 0.00% | -0.53% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.23 | -0.25 | -0.94 | -0.95 |
7 Days Ago | -0.23 | -0.25 | -0.94 | -0.95 |
30 Days Ago | -0.22 | -0.22 | -0.89 | -0.74 |
60 Days Ago | -0.22 | -0.22 | -0.89 | -0.74 |
90 Days Ago | -0.22 | -0.22 | -0.89 | -0.74 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.23 | -0.25 | -0.94 | -0.95 |
Zacks Consensus Estimate | -0.23 | -0.25 | -0.94 | -0.95 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.23 | -0.23 | -0.25 | -0.20 | NA |
Estimate | -0.22 | -0.24 | -0.23 | -0.21 | NA |
Difference | -0.01 | 0.01 | -0.02 | 0.01 | 0.00 |
Surprise | -4.55% | 4.17% | -8.70% | 4.76% | -1.08% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more